GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Equity-to-Asset

PharmaTher Holdings (XCNQ:PHRM) Equity-to-Asset : 0.91 (As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. PharmaTher Holdings's Total Stockholders Equity for the quarter that ended in Feb. 2024 was C$2.66 Mil. PharmaTher Holdings's Total Assets for the quarter that ended in Feb. 2024 was C$2.91 Mil.

The historical rank and industry rank for PharmaTher Holdings's Equity-to-Asset or its related term are showing as below:

XCNQ:PHRM' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.8   Med: 0.94   Max: 0.99
Current: 0.91

During the past 3 years, the highest Equity to Asset Ratio of PharmaTher Holdings was 0.99. The lowest was 0.80. And the median was 0.94.

XCNQ:PHRM's Equity-to-Asset is ranked better than
87.23% of 1558 companies
in the Biotechnology industry
Industry Median: 0.67 vs XCNQ:PHRM: 0.91

PharmaTher Holdings Equity-to-Asset Historical Data

The historical data trend for PharmaTher Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Equity-to-Asset Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Equity-to-Asset
0.94 0.97 0.86

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.93 0.86 0.84 0.85 0.91

Competitive Comparison of PharmaTher Holdings's Equity-to-Asset

For the Biotechnology subindustry, PharmaTher Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaTher Holdings's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Equity-to-Asset falls into.



PharmaTher Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

PharmaTher Holdings's Equity to Asset Ratio for the fiscal year that ended in May. 2023 is calculated as

Equity to Asset (A: May. 2023 )=Total Stockholders Equity/Total Assets
=5.417/6.31
=

PharmaTher Holdings's Equity to Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

Equity to Asset (Q: Feb. 2024 )=Total Stockholders Equity/Total Assets
=2.662/2.914
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaTher Holdings  (XCNQ:PHRM) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


PharmaTher Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines